Specialty Pharmaceuticals

The Utah Division of Purchasing is issuing a courtesy posting on behalf of MMCAP Infuse for a comprehensive Specialty Pharmaceuticals procurement opportunity. The solicitation, identified by reference number NH19072, seeks proposals for pharmaceutical products, immunomodulating drugs, vaccines, antigens, and specialized healthcare provider services across multiple medical disciplines including pharmacy, radiology, diagnostics, and therapy services. The request for proposal (RFP) was opened on April 30, 2019, at 8:30 AM MDT and will close on June 14, 2019, at 1:00 PM MDT. Vendors must submit responses directly to Nick Hughes (nhughes@utah.gov) and are required to review the complete solicitation document for full compliance requirements. The procurement covers commodity codes 51000 (pharmaceutical products), 51200 (immunomodulating drugs), and 85121 (healthcare provider specialist services), with all transactions to be conducted in US Dollars.

While specific set-aside designations are not explicitly detailed in the provided documentation, interested vendors must engage directly with MMCAP Infuse to obtain complete solicitation details. The procurement appears to be a multi-jurisdictional contract targeting pharmaceutical and healthcare service providers, with responses to be directed to the Minnesota Office of State Procurement. Potential bidders are advised that the contract award will not be posted on the Utah Public Procurement Place website, and any questions regarding the RFP should be emailed to mmcap.rfp@state.mn.us. Although specific budget ranges or award values are not specified in the current documentation, vendors should anticipate a comprehensive procurement process covering a wide range of specialty pharmaceutical and healthcare provider services. Interested parties are strongly encouraged to visit the MMCAP Infuse website for additional information and complete solicitation requirements.